Συγγραφείς:
Coleman, R.
Hadji, P.
Body, J.-J.
Santini, D.
Chow, E.
Terpos, E.
Oudard, S.
Bruland, Ø.
Flamen, P.
Kurth, A.
Van Poznak, C.
Aapro, M.
Jordan, K.
ESMO Guidelines Committee
Λέξεις-κλειδιά:
antineoplastic agent; biological marker; bisphosphonic acid derivative; calcium; denosumab; fluorodeoxyglucose f 18; ibandronic acid; iodine 131; placebo; radioisotope; radium 223; samarium 153; sodium fluoride f 18; technetium 99m; unclassified drug; vitamin D; zoledronic acid, Article; bone biopsy; bone metastasis; bone pain; bone scintiscanning; breast cancer; calcium balance; cancer chemotherapy; cancer epidemiology; cancer hormone therapy; cancer incidence; cancer palliative therapy; cancer radiotherapy; computer assisted tomography; conceptual framework; cryoablation; diffusion weighted imaging; drug safety; elderly care; external beam radiotherapy; femur fracture; human; jaw osteonecrosis; kidney cancer; lung cancer; metastasis inhibition; molecular imaging; multidisciplinary team; nuclear magnetic resonance imaging; orthopedic surgery; osteolysis; osteoporosis; overall survival; pathophysiology; patient monitoring; percutaneous vertebroplasty; personalized medicine; positron emission tomography; practice guideline; priority journal; prostate cancer; quality of life; radiofrequency ablation; single photon emission computed tomography; solid malignant neoplasm; spine metastasis; bone density; cancer staging; multimodality cancer therapy; neoplasm; practice guideline, Bone Density; Combined Modality Therapy; Humans; Neoplasm Staging; Neoplasms
